Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/10292
Type
ArticleCopyright
Restricted access
Collections
- IFF - Artigos de Periódicos [1287]
Metadata
Show full item record
IDENTIFICATION OF LOSS-OF-FUNCTION MUTATIONS OF SLC35D1IN PATIENTS WITH SCHNECKENBECKEN DYSPLASIA, BUT NOT WITH OTHER SEVERE SPONDYLODYSPLASTIC DYSPLASIAS GROUP DISEASES
Author
Affilliation
Center for Genomic Medicine. Laboratory of Bone and Joint Diseases. Minato-ku, Tokyo, Japan.
Istanbul University. Istanbul Medical Faculty. Medical Genetics Department. Istanbul, Turkey.
Research Center for Allergy and Immunology. Laboratory for Developmental Genetics. Yokohama, Kanagawa, Japan.
Tokyo Metropolitan Kiyose Children’s Hospital. Department of Radiology. Kiyose, Tokyo, Japan.
Saitama Children’s Medical Center. Division of Medical Genetics. Saitama, Japan.
Hacettepe University School of Medicine. Ihsan Dogramaci Children’s Hospital. Department of Pediatrics. Ankara, Turkey
Fundação. Oswaldo Cruz. Instituto Fernandes Figueira. Centro de Genética Médica. Rio de Janeiro, RJ, Brasil.
Istanbul University. Istanbul Medical Faculty. Medical Genetics Department. Istanbul, Turkey.
Research Center for Allergy and Immunology. Laboratory for Developmental Genetics. Yokohama, Kanagawa, Japan.
Cedars-Sinai Medical Center. Medical Genetics Research Institute. Los Angeles, California, USA.
University of Freiberg. Centrer for Pediatrics and Adolescent Medicine. Freiberg, Germany.
University of Freiberg. Centrer for Pediatrics and Adolescent Medicine. Freiberg, Germany. / University of Freiburg. Institute for Human Genetics. Freiburg, Germany.
Center for Genomic Medicine. Laboratory of Bone and Joint Diseases. Minato-ku, Tokyo, Japan.
Istanbul University. Istanbul Medical Faculty. Medical Genetics Department. Istanbul, Turkey.
Research Center for Allergy and Immunology. Laboratory for Developmental Genetics. Yokohama, Kanagawa, Japan.
Tokyo Metropolitan Kiyose Children’s Hospital. Department of Radiology. Kiyose, Tokyo, Japan.
Saitama Children’s Medical Center. Division of Medical Genetics. Saitama, Japan.
Hacettepe University School of Medicine. Ihsan Dogramaci Children’s Hospital. Department of Pediatrics. Ankara, Turkey
Fundação. Oswaldo Cruz. Instituto Fernandes Figueira. Centro de Genética Médica. Rio de Janeiro, RJ, Brasil.
Istanbul University. Istanbul Medical Faculty. Medical Genetics Department. Istanbul, Turkey.
Research Center for Allergy and Immunology. Laboratory for Developmental Genetics. Yokohama, Kanagawa, Japan.
Cedars-Sinai Medical Center. Medical Genetics Research Institute. Los Angeles, California, USA.
University of Freiberg. Centrer for Pediatrics and Adolescent Medicine. Freiberg, Germany.
University of Freiberg. Centrer for Pediatrics and Adolescent Medicine. Freiberg, Germany. / University of Freiburg. Institute for Human Genetics. Freiburg, Germany.
Center for Genomic Medicine. Laboratory of Bone and Joint Diseases. Minato-ku, Tokyo, Japan.
Abstract
Background—Schneckenbecken dysplasia (SBD) is an autosomal recessive lethal skeletal
dysplasia that is classified into the severe spondylodysplastic dysplasias (SSDD) group in the
international nosology for skeletal dysplasias. The radiological hallmark of SBD is the snaillike
configuration of the hypoplastic iliac bone. SLC35D1 (solute carrier-35D1) is a nucleotide-sugar
transporter involved in proteoglycan synthesis. Recently, based on human and mouse genetic
studies, we showed that loss-of-function mutations of the SLC35D1 gene (SLC35D1) cause SBD.
Object—To explore further the range of SLC35D1mutations in SBD and elucidate whether
SLC35D1mutations cause other skeletal dysplasias that belong to the SSDD group.Methods and results—We searched for SLC35D1mutations in five families with SBD and 15
patients with other SSDD group diseases, including achodrogenesis type 1A,
spondylometaphyseal dysplasia Sedaghatian type and fibrochondrogenesis. We identified four
novel mutations, c.319C>T (p.R107X), IVS4+3A>G, a 4959-bp deletion causing the removal of
exon 7 (p.R178fsX15), and c.193A>C (p. T65P), in three SBD families. Exon trapping assay
showed IVS4+3A>G caused skipping of exon 4 and a frameshift (p.L109fsX18). Yeast
complementation assay showed the T65P mutant protein lost the transporter activity of nucleotide
sugars. Therefore, all these mutations result in loss of function. No SLC35D1mutations were
identified in all patients with other SSDD group diseases.
Conclusion—Our findings suggest that SLC35D1loss-of-function mutations result consistently
in SBD and are exclusive to SBD.
Share